-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Kinnate Biopharma Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q4 2023.
- Kinnate Biopharma Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $3.83M, a 22.5% decline year-over-year.
- Kinnate Biopharma Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $19.9M, a 1.72% increase year-over-year.
- Kinnate Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19.9M, a 1.72% increase from 2022.
- Kinnate Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2022 was $19.6M, a 30.4% increase from 2021.
- Kinnate Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2021 was $15M, a 506% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)